| Website | kearnyvp.com |
| Phone | 415-364-5999 |
| Employees | |
| Description | venture capital firm |
Kearny Venture Partners is a venture capital firm specializing in investments in incubation, seed, early, mid, and later stage investments. The firm prefers to invest in healthcare sector with a focus on medical devices and drugs, both small molecules and biopharmaceuticals. It typically invests between $2 million and $8 million initially and between $10 million and $15 million per company. Kearny Venture Partners is based in San Francisco, California.
| Company | Date | Round | Size | Participants |
| ViewRay | 5/13 | Series D | $15M | 5 |
| Aerpio Therapeutics | 8/12 | Series A | $27M | 6 |
| TriVascular | 6/12 | Series D | $60M | 7 |
| ViewRay | 3/12 | Series C | $45M | 5 |
| Akebia Therapeutics | 1/12 | Series B | $4.1M | 7 |
| ViewRay | 9/11 | Venture Round | $10M | 5 |
| Akebia Therapeutics | 4/11 | Series B | $22M | 7 |
| NextWave Pharmaceuticals | 1/11 | Series C | $45M | 7 |
| ViewRay | 8/10 | Series C | $20M | 5 |
| TriVascular | 8/10 | Series C | $60M | 5 |
| Baxano | 6/10 | Series C | $30M | 6 |
| TriVascular | 11/09 | Series B | $30M | 4 |
| TriVascular | 3/08 | Series A | $65M | 4 |
| TriVascular2 | 3/08 | Series A | $65M | 4 |
